Teachers Advisors’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-172,019
Closed -$585K 3050
2018
Q3
$585K Sell
172,019
-1,688
-1% -$6.09K ﹤0.01% 2561
2018
Q2
$653K Buy
173,707
+9,704
+6% +$47.2K ﹤0.01% 2535
2018
Q1
$671K Hold
164,003
﹤0.01% 2393
2017
Q4
$763K Buy
164,003
+13,676
+9% +$75.4K ﹤0.01% 2368
2017
Q3
$1.07M Buy
150,327
+4,099
+3% +$29.5K ﹤0.01% 2197
2017
Q2
$1.06M Buy
146,228
+7,354
+5% +$46K ﹤0.01% 2192
2017
Q1
$855K Hold
138,874
﹤0.01% 2273
2016
Q4
$814K Buy
138,874
+4,402
+3% +$24.1K ﹤0.01% 2286
2016
Q3
$714K Hold
134,472
﹤0.01% 2269
2016
Q2
$890K Sell
134,472
-36,221
-21% -$203K ﹤0.01% 2087
2016
Q1
$797K Hold
170,693
﹤0.01% 2093
2015
Q4
$862K Buy
170,693
+17,568
+11% +$83.5K ﹤0.01% 2086
2015
Q3
$539K Hold
153,125
﹤0.01% 2345
2015
Q2
$1.53M Buy
153,125
+12,309
+9% +$132K ﹤0.01% 1866
2015
Q1
$1.79M Buy
140,816
+14,823
+12% +$191K ﹤0.01% 1712
2014
Q4
$1.78M Sell
125,993
-1,873
-1% -$29K ﹤0.01% 1703
2014
Q3
$1.76M Hold
127,866
﹤0.01% 1687
2014
Q2
$1.97M Sell
127,866
-5,141
-4% -$72.9K ﹤0.01% 1632
2014
Q1
$2.27M Buy
133,007
+16,120
+14% +$243K ﹤0.01% 1495
2013
Q4
$1.51M Buy
116,887
+4,320
+4% +$51.6K ﹤0.01% 1741
2013
Q3
$1.14M Buy
112,567
+2,803
+3% +$24.9K ﹤0.01% 1839
2013
Q2
$820K Buy
+109,764
New +$858K ﹤0.01% 1962

Teachers Advisors's KERX Position: Q4 2018 in Review

Teachers Advisors sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 172,019 shares — an estimated $585K sold.

Teachers Advisors first reported a position in KERX in Q2 2013 and held it in 22 quarters. The position peaked at $2.27M in Q1 2014. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

  • Teachers Advisors reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
  • Teachers Advisors sold 172,019 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $585K.
  • Teachers Advisors first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 22 quarters.
  • Teachers Advisors's Keryx Biopharmaceuticals Inc position peaked at $2.27M in Q1 2014.
  • 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Teachers Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.